Dakota Venture Group

Dakota Venture Group (DVG) is a venture capital investment fund operated by students at the University of North Dakota. Established in 2006, it holds the distinction of being the first entirely student-run venture capital fund in the United States. DVG offers students a unique opportunity to engage in all aspects of the investment process, including conducting due diligence, making final investment decisions, and negotiating deal terms. The organization focuses on investing in high-growth companies across the United States, providing a valuable experiential learning platform in the fields of venture capital and angel investing.

Hunter Beck

Chairman

Mason Benefield

Managing Associate

Brennen Bergdahl

Managing Director of Information Technology and Operations and Board Member

Paul Butler

Managing Associate

Dylan Diede

Managing Director, Finance

Tyler Eiken

Board Member and Managing Director, Finance

Austin Emineth

Managing Director of Information Technology and Operations, Managing Associate and Board Member

Dylan Foley

Managing Director, Finance

Dara Morehouse

Managing Director of Information Technology and Operations and Executive, Alumni

Grady Neer

Chairman

Jacob Oleksik

Managing Director of Finance, Managing Associate and Board Member

Amanda Perez

Managing Director of IT and Operations

4 past transactions

Voxello

Series A in 2016
Voxello, Inc. specializes in developing and marketing communication devices aimed at improving the interaction capabilities of disabled hospitalized patients. The company's flagship product, known as noddle, is a communication device that integrates with ventilators and utilizes Bluetooth technology to connect with other devices. Voxello's innovative approach includes patented technology that detects subtle gestures, allowing patients to access nurse call systems and utilize a proprietary chat application. Founded in 2013 and headquartered in Coralville, Iowa, Voxello aims to create universally adaptable assistive technology devices, including a range of input devices such as microphones and switches, to enhance communication for patients in hospitals and long-term care settings.

Youbetme

Series A in 2014
Youbetme is a consumer technology platform that facilitates peer-to-peer social betting, allowing users to place bets with friends on a variety of events. The service aims to enhance the social experience of betting, making it accessible to sports enthusiasts, college students, and young professionals looking for a fun way to engage in friendly wagers. The platform is designed to be user-friendly, featuring tools for tracking bets through a text message system, enabling users to bet from any location. Youbetme has received $1,225,000 in seed funding to support its marketing launch and ongoing development. The company was co-founded by Jason Neubauer and Justin Jarman, with a team that includes experienced professionals from the tech and gaming industries. The native iOS app is available for download, positioning Youbetme as a modern solution for social betting among friends.

Buzz360

Venture Round in 2014
Buzz360 LLC is a Minneapolis-based company that specializes in developing a software-as-a-service marketing automation platform designed for small businesses. Founded in 2011, Buzz360 provides tools that help entrepreneurs automate their marketing efforts, enabling them to attract new customers and foster repeat business. The platform features automated social media postings, customer reviews, and search engine optimization. It allows clients to send stay-in-touch emails, post to Facebook, and generate social referrals and feedback. Buzz360 also offers a white-label community platform, allowing media firms, marketing agents, and associations to create branded marketing solutions for small businesses. Its design supports multi-tenant capabilities, enabling partners to reach large sectors of the small business market effectively. By streamlining marketing processes, Buzz360 empowers small business owners to focus on their passions and enhance profitability.

EmboMedics

Series A in 2013
EmboMedics, Inc. is a medical company focused on the development and commercialization of embolization materials, both drug-loaded and unloaded, for various medical conditions. The company offers products for treating uterine fibroid embolization, trauma, benign prostatic hyperplasia, and trans-arterial chemoembolization. In particular, its trans-arterial chemoembolization technique involves coating small particles with chemotherapy drugs, allowing for targeted blockage of blood supply to tumors while simultaneously delivering chemotherapy agents. Founded in 2012, EmboMedics is headquartered in Minnesota.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.